179 related articles for article (PubMed ID: 7018412)
1. [Prospects in the field of the antipolio vaccination (author's transl)].
Focà A
Ann Sclavo; 1980; 22(1):22-6. PubMed ID: 7018412
[TBL] [Abstract][Full Text] [Related]
2. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
3. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
[No Abstract] [Full Text] [Related]
4. Rapid and accurate identification of poliovirus strains used for vaccine production.
Nijst OE; Mouthaan JJ; Mekkes DR; Jusic E; van der Avoort HG; Metz B
J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
[TBL] [Abstract][Full Text] [Related]
5. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
6. Sabin and Salk poliovirus vaccine: vice versa.
Cohen HH
Acta Leiden; 1987; 56():65-83. PubMed ID: 3329800
[No Abstract] [Full Text] [Related]
7. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains.
Verdijk P; Rots NY; Bakker WA
Expert Rev Vaccines; 2011 May; 10(5):635-44. PubMed ID: 21604984
[TBL] [Abstract][Full Text] [Related]
9. Salk vs. Sabin controversy.
Puliyel JM
Indian Pediatr; 1987 Aug; 24(8):690. PubMed ID: 3443513
[No Abstract] [Full Text] [Related]
10. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
[TBL] [Abstract][Full Text] [Related]
11. Some results of the work on mass immunization in the Soviet Union with live poliovirus vaccine prepared from Sabin strains.
CHUMAKOV MP
Bull World Health Organ; 1961; 25(1):79-91. PubMed ID: 13879389
[TBL] [Abstract][Full Text] [Related]
12. [Behavior of morbidity in poliomyelitis in Salerno province in relation to vaccination campaigns using the Salk method and using the Sabin method].
Santoro M
Ann Sanita Pubblica; 1966; 27(2):375-83. PubMed ID: 5960605
[No Abstract] [Full Text] [Related]
13. Effect of Sabin poliovirus vaccine on incidence of poliomyelitis in Italy.
Giovanardi A
JAMA; 1969 Jul; 209(4):525-8. PubMed ID: 4307421
[No Abstract] [Full Text] [Related]
14. Paralytic poliomyelitis--United States, 1980-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
[TBL] [Abstract][Full Text] [Related]
15. The present status of the Salk vaccine for the control of paralytic poliomyelitis.
VAN RIPER HE
N Y State J Med; 1956 Jul; 56(14):2229-37. PubMed ID: 13334836
[No Abstract] [Full Text] [Related]
16. Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk).
Dixon B
Br J Hosp Med; 1977 Dec; 18(6):595. PubMed ID: 342023
[No Abstract] [Full Text] [Related]
17. [100 years of studying poliomyelitis virus and nonpoliomyelitis enteroviruses].
Lashkevich VA
Vopr Virusol; 2008; 53(4):41-4. PubMed ID: 18756817
[TBL] [Abstract][Full Text] [Related]
18. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
[TBL] [Abstract][Full Text] [Related]
19. [A forgotten chapter of Mexican technology and science: Luis Gutiérrez Villegas and poliomyelitis in Mexico].
Velázquez-Arellano A
Gac Med Mex; 2017; 153(5):633-640. PubMed ID: 29099101
[TBL] [Abstract][Full Text] [Related]
20. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.
Bakker WA; Thomassen YE; van't Oever AG; Westdijk J; van Oijen MG; Sundermann LC; van't Veld P; Sleeman E; van Nimwegen FW; Hamidi A; Kersten GF; van den Heuvel N; Hendriks JT; van der Pol LA
Vaccine; 2011 Sep; 29(41):7188-96. PubMed ID: 21651934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
